Pharmacokinetic/Pharmacodynamic Studies in Drug Product Development
- 1 January 2002
- journal article
- review article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 91 (1) , 18-31
- https://doi.org/10.1002/jps.1167
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Impact of Population Pharmacokinetic- Pharmacodynamic Analyses on the Drug Development ProcessClinical Pharmacokinetics, 2000
- Population Pharmacokinetics/Toxicodynamics (PK/TD) Relationship of SAM486A in Phase I Studies in Patients with Advanced CancersThe Journal of Clinical Pharmacology, 2000
- The Pharmacokinetic Principles Behind Scaling from Preclinical Results to Phase I ProtocolsClinical Pharmacokinetics, 1999
- Population PharmacokineticsClinical Pharmacokinetics, 1999
- Predicting Effective Drug Concentrations for Individual PatientsClinical Pharmacokinetics, 1998
- Role of Population Pharmacokinetics in Drug DevelopmentClinical Pharmacokinetics, 1997
- Relevance of the Application of Pharmacokinetic-Pharmacodynamic Modelling Concepts in Drug DevelopmentClinical Pharmacokinetics, 1997
- Inhibition of Platelet Aggregation as a Surrogate MarkerThe Journal of Clinical Pharmacology, 1997
- The Use of Population Pharmacokinetics in Drug DevelopmentClinical Pharmacokinetics, 1996
- Receptor‐Based Pharmacokinetic‐Pharmacodynamic Analysis of CorticosteroidsThe Journal of Clinical Pharmacology, 1993